Fifty consecutive patients with ALI/ALF were recruited prospectively from admissions at VCU Medical Center. ALI was defined as liver injury in a patient with no known previous liver disease, an admission INR of ≥1.5, and a duration of illness of ≤26 weeks. ALF was defined as ALI in the presence of HE. Some patients in the current study population also participated in two previous studies exploring hemostasis in ALI/ALF.6, 8 For the present study, 13 healthy volunteer controls were also recruited for the collection of 5 mL of whole blood for plasma. Controls were of similar age (39 years) and gender distribution

(54% female) as the study population (P = 0.6 and 0.2, respectively). SIRS components were determined at time of admission to the study by standard criteria, and the presence of the SIRS was defined as two to four positive www.selleckchem.com/products/Neratinib(HKI-272).html SIRS components.24 Complications

of ALI/ALF, including bleeding, thrombosis, and infection, were defined previously6 and occurred late after admission (on or after day 3). Bleeding sites included gastric mucosal erosions (N = 6) and cutaneous (N = 3), none of which lead to the need for blood transfusion. Thrombotic events selleck compound included occlusion of renal replacement therapy (RRT) catheters (N = 6), portal venous thrombosis (N = 2), and limb vessel thrombosis (N = 1). Sites of infection included lung (N = 5), urine (N = 4), blood (N = 3), and ascites (N = 1) and were identified relatively late after admission (>3 days after admission). As per ALFSG protocol, outcomes (death, LT, or transplant-free survival [TFS]) were determined at day 21 after admission. Standard laboratories were collected

on admission to the hospital (day 1) and daily for 7 days. For the analyses herein, laboratories drawn on days 1 and 3 after admission were analyzed. Whole blood from days 1 and 3 was also collected for PPP in 5-mL citrated Vacutainer tubes. Because enrolled patients were purposely chosen to represent a wide range of liver injury severity, blood was drawn by in-dwelling venous catheters, radial artery catheters, and butterfly needle catheters, depending upon whether patients were in a floor bed medchemexpress or intensive care unit, and the availability of vascular access. Blood was centrifuged at 1,500×g for 20 minutes at room temperature, aliquotted, and PPP was frozen at −80°C within 2 hours of drawing. MPs were analyzed by Invitrox Sizing, Antigen Detection, and Enumeration (ISADE; Invitrox, Inc., Research Triangle Park, NC).23 Batches of 10-20 PPP samples, randomly selected, were injected into the detection chamber using a fixed volume of 200 μL/sample. Testing time for sizing and enumeration was 6 minutes/sample. To eliminate any contribution from buffer/diluent, background counts were subtracted from each sample result.